Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 021807
Company: MAYNE PHARMA COMMRCL
Company: MAYNE PHARMA COMMRCL
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
SOLTAMOX | TAMOXIFEN CITRATE | EQ 20MG BASE/10ML | SOLUTION;ORAL | Prescription | None | Yes | Yes |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
10/29/2005 | ORIG-1 | Approval | Type 3 - New Dosage Form | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021807lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/021807ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2005/021807s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
04/08/2019 | SUPPL-6 | Labeling-Package Insert, Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/021807Orig1s006ltr.pdf | |
09/25/2018 | SUPPL-5 | Efficacy-New Dosing Regimen |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021807s005lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/021807Orig1s005ltr.pdf | |
04/22/2015 | SUPPL-3 | Manufacturing (CMC) |
Label is not available on this site. |
||
01/28/2013 | SUPPL-2 | Manufacturing (CMC) |
Label is not available on this site. |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
04/08/2019 | SUPPL-6 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf | |
04/08/2019 | SUPPL-6 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021807s006lbl.pdf | |
09/25/2018 | SUPPL-5 | Efficacy-New Dosing Regimen | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021807s005lbl.pdf | |
10/29/2005 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/021807lbl.pdf |